Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01975363 · ClinicalTrials.gov registry record · NA
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01975363 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 29 participants.
The verdict
NCT01975363, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies a nanoemulsion formulation of curcumin in reducing inflammatory changes in breast tissue in obese women at high risk for breast cancer. Curcumin may reduce inflammation in breast tissue and fat. This may affect the risk of developing breast cancer.
Interventions
- DIETARY_SUPPLEMENT curcumin
- OTHER Biomarker analysis
- OTHER Assessment of Dietary Intake
- OTHER Daily Log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01975363
The ClinicalTrials.gov registry entry for NCT01975363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which curcumin is the first listed.
NCT01975363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01975363 about?
NCT01975363 is a clinical study titled "Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer". This randomized pilot clinical trial studies a nanoemulsion formulation of curcumin in reducing inflammatory changes in breast tissue in obese women at high risk for breast cancer. Curcumin may reduce inflammation in breast tissue and fat. This may affect the risk of developing breast cancer.
What is the current status of trial NCT01975363?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-06. Estimated completion is 2016-09-19.
What interventions are being tested in trial NCT01975363?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT), Biomarker analysis (OTHER), Assessment of Dietary Intake (OTHER), Daily Log (OTHER).
Who is sponsoring clinical trial NCT01975363?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.